Offer - Urjas Oil for just ₹ 1 X
Olmin Trio 40 Tablet is a prescription drug, available for use as Tablet. Other than this, Olmin Trio 40 Tablet has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Olmin Trio 40 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Common side effects of Olmin Trio 40 Tablet include Upper respiratory tract infection, Loss of appetite, Gastric Irritation. Besides the aforementioned side effects, there are other adverse effects of Olmin Trio 40 Tablet as well, which are listed below. These side effects of Olmin Trio 40 Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Olmin Trio 40 Tablet's effect is Mild during pregnancy and Mild for lactating mothers. Further, the section on Olmin Trio 40 Tablet related warnings talks about Olmin Trio 40 Tablet's effects on the liver, heart and kidney.
Olmin Trio 40 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Low Blood Pressure (Hypotension) are examples of such conditions. Some other conditions that can be affected by Olmin Trio 40 Tablet are listed in the contraindications section below.
Drug reaction of Olmin Trio 40 Tablet with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Olmin Trio 40 Tablet is not safe while driving, and is is not addictive in nature.
Olmin Trio 40 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olmin Trio 40 Tablet safe for pregnant women?
Olmin Trio has mild to no side effects in pregnant women.
Is the use of Olmin Trio 40 Tablet safe during breastfeeding?
Breastfeeding women can take Olmin Trio as it bears very minor side effects for them.
What is the effect of Olmin Trio 40 Tablet on the Kidneys?
Olmin Trio rarely harms the kidneys.
What is the effect of Olmin Trio 40 Tablet on the Liver?
Olmin Trio has very mild side effects on the liver.
What is the effect of Olmin Trio 40 Tablet on the Heart?
Side effects of Olmin Trio rarely affect the heart.
Olmin Trio 40 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olmin Trio 40 Tablet unless your doctor advises you to do so -
Is this Olmin Trio 40 Tablet habit forming or addictive?
No, you will not get addicted to Olmin Trio 40 Tablet.
Interaction between Food and Olmin Trio 40 Tablet
Olmin Trio 40 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Olmin Trio 40 Tablet
Consuming Olmin Trio 40 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448